Nihon Kohden (OTCMKTS:NHNKY) Shares Up 7.9% – Time to Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKYGet Free Report) shot up 7.9% during mid-day trading on Monday . The company traded as high as $9.44 and last traded at $9.40. 2,946 shares traded hands during trading, a decline of 90% from the average session volume of 29,891 shares. The stock had previously closed at $8.71.

Analysts Set New Price Targets

A number of equities analysts have issued reports on NHNKY shares. UBS Group upgraded Nihon Kohden from a “hold” rating to a “strong-buy” rating in a report on Monday, January 19th. Zacks Research upgraded Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy”.

Read Our Latest Analysis on Nihon Kohden

Nihon Kohden Stock Up 0.8%

The firm has a 50 day moving average of $9.44 and a two-hundred day moving average of $10.49. The firm has a market capitalization of $1.60 billion, a price-to-earnings ratio of 15.90 and a beta of 0.41.

Nihon Kohden (OTCMKTS:NHNKYGet Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.24 by $0.10. The firm had revenue of $453.10 million during the quarter, compared to the consensus estimate of $414.40 million. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%. Sell-side analysts forecast that Nihon Kohden Corporation will post 0.61 EPS for the current fiscal year.

About Nihon Kohden

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

See Also

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.